Close Menu

NEW YORK – Adaptive Biotechnologies reported a 91 percent increase in second quarter revenues after the close of the market on Tuesday.

For the quarter ended June 30, 2019, Adaptive reported $22.1 million in revenues, up from $11.6 million during the year-ago period, and beating the consensus Wall Street estimate of $19.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.